These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8771740)

  • 1. [The effect of drug preparations on the expression of the persistence properties of uropathogenic strains of enterobacteria].
    Chelpachenko OE; Zykova LS
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (3):84-6. PubMed ID: 8771740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infectious drug resistance factors in Enterobacteriaceae producing urinary tract infections].
    Lachmajer M; Bugalski R
    Med Dosw Mikrobiol; 1972; 24(2):95-101. PubMed ID: 5035828
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary infections by enterobacteriaceae resistent to antimicrobial agents].
    Ales Reinlein JM; Vela Navarrete R; Fernández Puentes MC; Silva M
    Rev Clin Esp; 1973 Aug; 130(4):295-300. PubMed ID: 4755593
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolates associated with community and nosocomial urinary tract infection in East London, UK.
    Amin AK; Wareham DW
    Int J Antimicrob Agents; 2009 Nov; 34(5):490-1. PubMed ID: 19261447
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance to oral antibiotics in urinary coliform strains isolated between 2000 and 2008 in Sønderborg area, Denmark.
    Cybulski Z; Kjaeldgaard P
    Int J Antimicrob Agents; 2010 May; 35(5):516-7. PubMed ID: 20202798
    [No Abstract]   [Full Text] [Related]  

  • 6. Fosfomycin: an oral agent for urinary infection caused by extended spectrum beta-lactamase producing organisms.
    Hutley EJ; Chand MA; Hounsome G; Kelsey MC
    J Infect; 2010 Apr; 60(4):308-9. PubMed ID: 20114062
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epidemiological profile of uropathogenic enterobacteria producing extended spectrum beta-lactamases].
    Sbiti M; Lahmadi K; Louzi L
    Pan Afr Med J; 2017; 28():29. PubMed ID: 29138665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of ESBL-producing enterobacteria associated to community-acquired monomicrobial urinary tract infections and antimicrobial susceptibility trends over a 9-year period.
    Dias VC; da Silva VL; Firmo Ede O; Bastos LQ; Bastos AN; Bastos RV; Diniz CG
    J Chemother; 2012 Jun; 24(3):178-81. PubMed ID: 22759764
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary tract isolates of Enterobacteriaceae from hospitalized patients in the Arkhangelsk region, Russia: antimicrobial susceptibility and characterization of extended-spectrum beta-lactamases strains.
    Vorobieva V; Naseer U; Bazhukova T; Semenova N; Haldorsen BC; Aasnaes B; Simonsen GS; Sundsfjord A
    Scand J Infect Dis; 2010 Oct; 42(10):797-800. PubMed ID: 20438286
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bacterial flora and its sensitivity to antibiotics in urinary tract infections in children].
    Szozda G; Nowakowska K
    Probl Med Wieku Rozwoj; 1984; 13():59-67. PubMed ID: 6442420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for qnrB1 and aac(6')-Ib-cr in CTX-M-15-producing uropathogenic Enterobacteriaceae in an Italian teaching hospital.
    Perilli M; Forcella C; Celenza G; Frascaria P; Segatore B; Pellegrini C; Amicosante G
    Diagn Microbiol Infect Dis; 2009 May; 64(1):90-3. PubMed ID: 19249178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Doi A; Shimada T; Harada S; Iwata K; Kamiya T
    Int J Infect Dis; 2013 Mar; 17(3):e159-63. PubMed ID: 23140947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aminoglycoside resistance of enterobacteria isolated from urinary infections in surgical departments].
    Muntean D; Licker M; Berceanu-Văduva D; Crăciunescu M; Hogea E; Popa M; Adămut M; Rădulescu M; Moldovan R
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(2):99-102. PubMed ID: 19856848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial susceptibility in urinary tract infections caused by ESBL- and non-ESBL-producing Enterobacteriaceae in hospitalized/outpatient-, sex-, age-matched patients].
    Jaqueti-Aroca J; Molina-Esteban L; Limón-Yelmo A; García-Arata I
    Rev Esp Quimioter; 2018 Feb; 31(1):63-65. PubMed ID: 29390602
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility to β-lactams and quinolones of Enterobacteriaceae isolated from urinary tract infections in outpatients.
    Marchisio M; Porto A; Joris R; Rico M; Baroni MR; Di Conza J
    Braz J Microbiol; 2015; 46(4):1155-9. PubMed ID: 26691475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.
    Pogue JM; Marchaim D; Abreu-Lanfranco O; Sunkara B; Mynatt RP; Zhao JJ; Bheemreddy S; Hayakawa K; Martin ET; Dhar S; Kaye KS; Lephart PR
    J Antibiot (Tokyo); 2013 Oct; 66(10):625-7. PubMed ID: 23715037
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of Clinical and Laboratory Standards Institute breakpoint changes on susceptibility rates of cephalosporins in uncomplicated urinary tract infections caused by Enterobacteriaceae.
    Bunnell KL; Wenzler E; Harrington AT; Danziger LH
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):335-336. PubMed ID: 29395714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
    Lagree M; Bontemps S; Dessein R; Angoulvant F; Madhi F; Martinot A; Cohen R; Dubos F;
    Med Mal Infect; 2018 May; 48(3):193-201. PubMed ID: 29449049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from CLSI to EUCAST XL susceptibility breakpoint: its implication in urinary tract infection in men.
    Aguirre-Quiñonero A; Lecaroz Agara MC; Canut Blasco A
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1813-1815. PubMed ID: 29936620
    [No Abstract]   [Full Text] [Related]  

  • 20. Ciprofloxacin in the treatment of urinary tract infection due to enterobacteria.
    Guibert J; Destrée D; Konopka C; Acar J
    Eur J Clin Microbiol; 1986 Apr; 5(2):247-8. PubMed ID: 2941292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.